Prostate cancer may be aggressive and deadly, so accurate diagnosis is required
Prostate cancer screening not so accurate: better ways of diagnosing needed - health science news

A large scale-study, including over 400,000 men, looked at the accuracy of the prostate cancer screening (PSA) tests and their long-term benefits. The study found that one-time PSA screening in asymptomatic men has serious flaws and missed diagnosing some aggressive forms of prostate cancer. The researchers concluded that, although the test is harmless, it does not significantly contribute to saving lives after a follow-up of ten years. More accurate tools for diagnosing cancer are required.

Read the full story: University of Bristol
Scientific publication: Journal of the American Medical Association (JAMA)